<DOC>
	<DOCNO>NCT00933764</DOCNO>
	<brief_summary>This multi-center study design assess accuracy precision Cholestech LDX Cardiac hsCRP test quantitative determination C-reactive protein ( CRP ) whole blood , serum plasma individual assess risk cardiovascular disease . The Cholestech LDX Cardiac hsCRP test consist CRP cassette LDX analyzer measure CRP high sensitivity fingerstick venous whole blood point-of-care ( POC ) . The result study intend use regulatory 510k filing use vitro diagnostic test .</brief_summary>
	<brief_title>Clinical Performance Evaluation Cholestech LDX Cardiac hsCRP Test ( CLEAR )</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>1 . Adults ( 18 year age old ) present physician 's office outpatient clinic routine prescheduled visit candidate cardiovascular risk assessment . 2 . Willing able provide write informed consent comply study procedure . 1 . Known hematocrit &lt; 30 % &gt; 52 % ; 2 . History medical condition risk cardiovascular disease may elevate CRP list Appendix B ( e.g. , tissue damage , infection , inflammation , malignant neoplasia ) 3 . Vulnerable population deem inappropriate study site 's principal investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>